SHANGHAI KAIBAO: Net profit for the third quarter was 65.0877 million yuan, a decrease of 13.13%Zhitong·Oct 28, 2025 at 06:52 AM300039+1.66%
SHANGHAI KAIBAO released its performance for the first half of the year, with a net profit attributable to the parent company of 122 million yuan, a decrease of 14.20%Zhitong·Aug 27, 2025 at 07:27 AM300039+1.66%
SHANGHAI KAIBAO plans to sell no more than 6.2011 million shares of SHANGHAI YIZHONG at an opportune timeZhitong·Jul 16, 2025 at 06:15 AM300039+1.66%688091+1.59%
The concerted action party of the actual controller of SHANGHAI KAIBAO, Kaiyi Trading, plans to reduce its holdings by no more than 1%Zhitong·Jul 1, 2025 at 09:20 AM300039+1.66%
SHANGHAI KAIBAO has obtained the drug registration certificate for Phlegm-Heat Clearing CapsulesZhitong·Jul 1, 2025 at 03:11 AM300039+1.66%
SHANGHAI KAIBAO and others invest to establish a technology company, including Internet of Things-related businessesZhitong·Apr 16, 2025 at 02:09 AM300039+1.66%
SHANGHAI KAIBAO released its 2024 annual performance, with a net profit attributable to the parent company of 376 million yuan, an increase of 14.55%Zhitong·Apr 15, 2025 at 08:33 AM300039+1.66%
SHANGHAI KAIBAO released its first-quarter performance, with a net profit attributable to the parent company of 84.2928 million yuan, a decrease of 4.71%Zhitong·Apr 15, 2025 at 08:29 AM300039+1.66%
SHANGHAI KAIBAO's wholly-owned subsidiary has obtained a drug registration certificateZhitong·Mar 10, 2025 at 06:06 AM300039+1.66%
SHANGHAI KAIBAO invests in a new medical technology company in HainanZhitong·Feb 12, 2025 at 11:55 PM300039+1.66%
SHANGHAI KAIBAO: Linggui Zhushugan Decoction Granules have completed drug registrationZhitong·Feb 7, 2025 at 02:26 AM300039+1.66%
